Watanabe Todd

See Remarks | President And CEO

1 company

Strong

Trades Analyzed

12M Win Rate

69.8%

Avg 3M Return

+4.5%

Avg 12M Return

+14.0%

Watanabe Todd is a See Remarks at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 8 sells.

Estimated insider holdings value: $19.4M based on current market prices.

Holdings by Company

ARQTNov 24, 2025

Current Shares740.5K

Value$19.41M

Net Activity-376,935

Bought: 7.5KSold: 384.4K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 3, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	19,301	$12.70	$245,122.70	-2.3%	+21.4%	+106.4%
Dec 20, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	15,000	$15.17	$227,566.50	-1.8%	+11.9%	+86.9%
Nov 30, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Buy	6,038	$3.52	$21,250.03	+0.4%	+5.0%	+132.9%
Nov 4, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	13,871	$8.68	$120,458.54	-1.6%	+45.5%	+175.3%
Aug 2, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	14,487	$9.02	$130,648.11	-1.7%	-10.2%	+54.5%
May 2, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	13,783	$8.74	$120,433.10	-1.6%	+17.1%	+77.2%
Mar 4, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	14,903	$11.12	$165,739.24	-1.7%	-25.4%	+22.4%
Feb 28, 2024	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	2,465	$10.60	$26,129.00	-0.3%	-14.7%	+23.0%
May 31, 2023	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Buy	1,463	$6.38	$9,333.94	+0.3%	+16.4%	+15.3%
Mar 6, 2023	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	2,435	$15.26	$37,167.35	-0.7%	-41.1%	-25.0%